Neoleukin Therapeutics Inc (NAS:NLTX)
$ 3.49 0 (0%) Market Cap: 8.20 Mil Enterprise Value: -35.02 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 22/100

Q1 2023 Capricor Therapeutics Inc Earnings Call Transcript

May 11, 2023 / 08:30PM GMT
Release Date Price: $17.63 (-1.57%)
Operator

Good afternoon, ladies and gentlemen. This is the conference operator. Welcome to the Capricor first quarter 2023 financial results and corporate update call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to our host, Mr. AJ Bergmann, Capricor's Chief Financial Officer.

AJ Bergmann
Capricor Therapeutics, Inc. - CFO

Thank you, and thank you for joining today's call. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies, our plans to present or report additional data, our plans regarding regulatory filings, potential regulatory developments involving our product candidates, manufacturing capabilities, potential milestone payments, and our possible uses

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot